Drug Therapy for Rheumatoid Arthritis in Adults
What To Discuss With Your Patients and Their Caregivers
In discussions with patients who have rheumatoid arthritis (RA) and their caregivers, topics related to the comparative effectiveness review? evidence include the natural history of RA, the role of disease-modifying anti-rheumatic drugs (DMARDs) in reducing symptoms and improving disease control, the potential benefits and adverse effects of DMARDs, changes in lifestyle that can help relieve symptoms (e.g., diet and exercise), and ?patient and caregiver preferences and values regarding treatment.
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic DMARD | withdrawal | adverse events | adverse effects | certolizumab pegol | etanercept | rituximab | anakinra | infliximab
- Donahue KE, Jonas D, Hansen RA, et al. Drug Therapy for Rheumatoid Arthritis in Adults: An Update. Comparative Effectiveness Review No. 55 (Prepared by the RTI International–University of North Carolina Evidence-based Practice Center under Contract No. 290-2007-10056-I). Rockville, MD: Agency for Healthcare Research and Quality; April 2012. AHRQ Publication No. 12-EHC025-EF. Available at www.effectivehealthcare.ahrq.gov/dmardsra.cfm.
Your slide tray is being processed.